International troika drives biomanufacturing platforms

GE Healthcare has teamed with Sweden's iBio and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine manufacturing gear. The arrangement capitalizes on GE's global life sciences muscle, the iBioLaunch plant-based vaccine and therapeutic protein manufacturing platform, and Fraunhofer's vaccine and molecular biology expertise. GE will supply bioprocessing products and process expertise for integration with the iBioLaunch platform. It will also support the development of products based on the iBioLaunch platform and product offering. iBio release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.